...
首页> 外文期刊>International braz j urol >High-grade Primary Renal Leiomyosarcoma
【24h】

High-grade Primary Renal Leiomyosarcoma

机译:高级原发性肾脏leiomyosarcoma

获取原文

摘要

Objectıve To investigate the clinical characteristics, prognosis, survival and diagnosis of high-grade primary renal leiomyosarcoma. Materıals and Methods From January 2003 to April 2013, 10 cases of high-grade primary renal leiomyosarcoma were retrospectively reviewed. We analyzed clinical manifestations, treatment and prognosis of our group and correlated to the literature. Results Ten cases (five male and five female patients; age range 43–77 years, mean=57±std d:12.3 ) were enrolled. The mean diameter of the tumor masses was 9.35±4.5 cm (range 3-18 cm). 40% of the patients were asymptomatic while the major symptom of 60% patients was lumbar pain. Nephrectomy was performed in 90% of patients. Partial nephrectomy surgery was preferred for only one patient. Pleomorphism and necrosis with high-grade, pink spindle cell cytoplasm were viewed in all patients. All patients were high-grade, pink spindle cell cytoplasm and pleomorfism and necrosis were observed in all. In an immunohistochemical examination, vimentin was seen in 100%, desmin in 90% and smooth muscle actin in 80% of the patients. CD117 was negative in all patients. All of the cases were followed-up, and the time of survival varied from 6 to 68 months (mean 23.9±std d:20.1). No patient received adjuvant CTx and/or RTx. Conclusıon High-grade primary renal leiomyosarcomas (LMSs) are rare and highly malignant and the prognosis is poor. Early diagnosis and radical nephrectomy can prolong the patient’s life. Surgery is the main treatment modality for renal (leiomyosarcoma) LMS.
机译:Objectıve探讨高级原代肾间肌肉瘤的临床特征,预后,存活和诊断。 2003年1月至2013年4月的母材和方法,回顾性审查了10例高等原代肾间肌肉肉瘤。我们分析了我们小组的临床表现,治疗和预后并与文献相关。结果十例(五个男性和五位女性患者;年龄范围43-77岁,平均= 57±STD D:12.3)。肿瘤质量的平均直径为9.35±4.5cm(范围3-18厘米)。 40%的患者无症状,而60%患者的主要症状是腰痛。肾切除术在90%的患者中进行。部分肾切除手术仅适用于一名患者。在所有患者中都观察了含有高档粉红色主轴细胞细胞质的渗透和坏死。所有患者都是高档,粉红色的主轴细胞质细胞质和渗过冬症和滋润和坏死。在免疫组织化学检查中,Vimentin在100%中观察到90%,患者的80%和肌肉平滑肌肌动蛋白。 CD117在所有患者中都是阴性的。所有病例均进行随访,生存时间从6〜68个月内变化(平均23.9±std d:20.1)。没有患者接受佐剂CTX和/或RTX。 Compualıon高级原发性肾脏平滑肌肉瘤(LMSS)是罕见的,极度恶性,预后差。早期诊断和激进的肾切除术可以延长患者的生命。手术是肾(Leiomyosarcoma)LMS的主要治疗方式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号